|
Re: Resverlogix Announces Proposed Offering of Units
|
2
|
Resverlogix Corp.
|
May 14, 2019 08:31PM
|
|
Re: Resverlogix Announces Participation at Prominent Industry and Investor Conferences
|
2
|
Resverlogix Corp.
|
Mar 11, 2019 10:32AM
|
|
Re: Resverlogix Announces Participation at Prominent Industry and Investor Conferences
|
6
|
Resverlogix Corp.
|
Mar 11, 2019 10:54PM
|
|
Re: Resverlogix Announces Participation at Prominent Industry and Investor Conferences
|
5
|
Resverlogix Corp.
|
Mar 12, 2019 01:22PM
|
|
Re: Resverlogix Announces Participation at Prominent Industry and Investor Conferences
|
4
|
Resverlogix Corp.
|
Mar 11, 2019 09:29AM
|
|
Re: Resverlogix Announces Participation at Prominent Industry and Investor Conferences
|
5
|
Resverlogix Corp.
|
Mar 11, 2019 09:38AM
|
|
Re: Resverlogix Announces New Insights into the Mechanism of Apabetalone's Cardioprotective Benefit in Chronic Kidney Disease Patients
|
3
|
Resverlogix Corp.
|
Jun 13, 2023 11:58AM
|
|
Re: Resverlogix Announces New Insights into the Mechanism of Apabetalone's Cardioprotective Benefit in Chronic Kidney Disease Patients
|
3
|
Resverlogix Corp.
|
Jun 14, 2023 09:18AM
|
|
Re: Resverlogix Announces FDA Confirmation Regarding Filing Pathway for Apabetalone
|
4
|
Resverlogix Corp.
|
Jun 16, 2018 01:37AM
|
|
Re: Resverlogix Announces Conversion of US$12 Million Debenture Strengthening Balance Sheet
|
9
|
Resverlogix Corp.
|
Oct 14, 2020 10:30PM
|
|
Re: Resverlogix Announces Change in Fiscal Year-End to December 31
|
4
|
Resverlogix Corp.
|
Mar 14, 2021 11:24PM
|
|
Re: Resverlogix Announces a Favorable Outlook Based on New Cardiovascular Disease Treatment Guidelines for Patients with Type 2 Diabetes
|
6
|
Resverlogix Corp.
|
Aug 29, 2023 01:39PM
|
|
Re: Resverlogix and the Toronto Maple Leafs.....
|
2
|
Resverlogix Corp.
|
Apr 24, 2017 01:14AM
|
|
Re: RESVERLOGIX AND MEDISON PHARMA LTD. ANNOUNCE STRATEGIC LICENSING AGREEMENT
|
4
|
Resverlogix Corp.
|
Jan 08, 2018 05:18PM
|
|
Re: RESVERLOGIX AND MEDISON PHARMA LTD. ANNOUNCE STRATEGIC LICENSING AGREEMENT
|
5
|
Resverlogix Corp.
|
Jan 10, 2018 12:31AM
|
|
Re: Resverlogix (RVX) Reports Fiscal Year 2017 Results
|
8
|
Resverlogix Corp.
|
Aug 15, 2017 03:58PM
|
|
Re: Resverlogix (RVX) Reports Fiscal Year 2017 Results
|
3
|
Resverlogix Corp.
|
Aug 15, 2017 10:11AM
|
|
Re: Response from Sarah -were still a go
|
2
|
Resverlogix Corp.
|
Dec 02, 2021 04:54PM
|
|
Re: Report Of Exempt Distribution.
|
2
|
Zenith Epigenetics
|
Apr 18, 2024 12:30AM
|
|
Re: Report of exempt distribution
|
1
|
Resverlogix Corp.
|
Nov 11, 2020 01:15AM
|
